tiprankstipranks
Trending News
More News >
Cvrx, Inc. (CVRX)
:CVRX
US Market
Advertisement

CVRx (CVRX) Earnings Dates, Call Summary & Reports

Compare
193 Followers

Earnings Data

Report Date
Jan 22, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.45
Last Year’s EPS
-0.43
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 05, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflects substantial progress with a notable increase in revenue, expanded commercial footprint, and improved gross margins. However, challenges remain with increased R&D expenses, higher interest expenses, and a net loss. The positive developments in clinical evidence and approval of a Category I CPT code are promising for future growth.
Company Guidance
During the CVRx Third Quarter 2025 Earnings Conference Call, the company provided updated financial guidance, forecasting full-year revenue between $55.6 million and $56.6 million, with a gross margin expectation of 85% to 86%. Operating expenses are projected to be between $98 million and $99 million. For the fourth quarter of 2025, CVRx anticipates revenue between $15 million and $16 million. The company also highlighted a successful third quarter with $14.7 million in revenue, a 10% increase year-over-year, and a gross margin of 87%. The call emphasized the progress of their strategic priorities, including the development of a world-class sales organization and enhancing patient access to Barostim therapy. Additionally, CVRx discussed the transition to a Category I CPT code effective January 1, 2026, which is expected to improve reimbursement processes and further support the adoption of Barostim therapy.
Revenue Growth
Revenue increased by 10% year-over-year, reaching $14.7 million for Q3 2025, driven by growth in the U.S. heart failure business.
Expansion of Active Implanting Centers
The company added 10 net new centers in Q3, bringing the total to 250 active implanting centers in the U.S.
Gross Margin Improvement
Gross margin increased to 87% in Q3 2025, up from 83% in Q3 2024, due to increased average selling prices and improved manufacturing efficiencies.
Category I CPT Code Approval
Transition to a Category I CPT code effective January 1, 2026, expected to improve reimbursement and reduce prior authorization denials.
Positive Developments in Clinical Evidence
Increasing flow of independent peer-reviewed publications reporting positive patient outcomes and reduced hospitalizations with Barostim therapy.

CVRx (CVRX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CVRX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jan 22, 2026
2025 (Q4)
-0.45 / -
-0.43
Nov 05, 2025
2025 (Q3)
-0.49 / -0.49
-0.5714.04% (+0.08)
Aug 04, 2025
2025 (Q2)
-0.52 / -0.57
-0.6512.31% (+0.08)
May 08, 2025
2025 (Q1)
-0.57 / -0.53
-1.0449.04% (+0.51)
Feb 04, 2025
2024 (Q4)
-0.38 / -0.43
-0.442.27% (+0.01)
Oct 29, 2024
2024 (Q3)
-0.50 / -0.57
-0.43-32.56% (-0.14)
Jul 29, 2024
2024 (Q2)
-0.55 / -0.65
-0.56-16.07% (-0.09)
Apr 30, 2024
2024 (Q1)
-0.54 / -1.04
-0.55-89.09% (-0.49)
Jan 25, 2024
2023 (Q4)
-0.54 / -0.44
-0.5113.73% (+0.07)
Oct 26, 2023
2023 (Q3)
-0.58 / -0.43
-0.4810.42% (+0.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CVRX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 05, 2025
$9.79$10.05+2.66%
Aug 04, 2025
$7.55$6.80-9.93%
May 08, 2025
$7.78$4.77-38.69%
Feb 04, 2025
$16.25$15.08-7.20%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cvrx, Inc. (CVRX) report earnings?
Cvrx, Inc. (CVRX) is schdueled to report earning on Jan 22, 2026, After Close (Confirmed).
    What is Cvrx, Inc. (CVRX) earnings time?
    Cvrx, Inc. (CVRX) earnings time is at Jan 22, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CVRX EPS forecast?
          CVRX EPS forecast for the fiscal quarter 2025 (Q4) is -0.45.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis